Sotera Health (NASDAQ:SHC) Sees Large Volume Increase – Time to Buy?

Shares of Sotera Health (NASDAQ:SHC) saw unusually-strong trading volume on Tuesday . Approximately 1,561,190 shares traded hands during mid-day trading, an increase of 33% from the previous session’s volume of 1,171,206 shares.The stock last traded at $11.36 and had previously closed at $11.66.

Analysts Set New Price Targets

Several brokerages recently commented on SHC. Barclays reduced their target price on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a report on Friday, February 28th. The Goldman Sachs Group assumed coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Sotera Health Trading Down 4.3 %

The business has a 50-day moving average price of $12.82 and a two-hundred day moving average price of $13.95. The stock has a market capitalization of $3.16 billion, a P/E ratio of 44.62 and a beta of 1.92. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Institutional Investors Weigh In On Sotera Health

Several institutional investors and hedge funds have recently bought and sold shares of SHC. Thrivent Financial for Lutherans increased its holdings in Sotera Health by 19.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 35,929 shares of the company’s stock valued at $600,000 after buying an additional 5,835 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Sotera Health by 18.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,348,917 shares of the company’s stock worth $22,527,000 after purchasing an additional 208,914 shares during the last quarter. Cerity Partners LLC acquired a new stake in shares of Sotera Health in the 3rd quarter valued at $1,489,000. The Manufacturers Life Insurance Company raised its holdings in shares of Sotera Health by 11.4% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 128,222 shares of the company’s stock worth $2,141,000 after buying an additional 13,157 shares in the last quarter. Finally, FMR LLC raised its holdings in shares of Sotera Health by 259.9% during the 3rd quarter. FMR LLC now owns 32,483 shares of the company’s stock worth $542,000 after buying an additional 23,457 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.